HF
CTSO icon

HRT Financial’s Cytosorbents Corp CTSO Stock Holding History

HRT Financial’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7K Buy
+14,113
New +$9.63K ﹤0.01% 3653
2025
Q1 		– Sell
-11,509
Closed -$10K – 2651
2024
Q4 		$10K Buy
+11,509
New +$11.3K ﹤0.01% 2281
2023
Q4 		– Sell
-10,256
Closed -$19K – 2427
2023
Q3 		$19K Buy
+10,256
New +$29.4K ﹤0.01% 2076
2021
Q3 		– Sell
-15,560
Closed -$117K – 3366
2021
Q2 		$117K Buy
+15,560
New +$131K ﹤0.01% 2556
2021
Q1 		– Sell
-15,262
Closed -$121K – 2757
2020
Q4 		$121K Buy
+15,262
New +$128K ﹤0.01% 1606

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial's CTSO Position: Q1 2026 in Review

HRT Financial opened a new position in Cytosorbents Corp (CTSO) in Q1 2026: 14,113 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #3653 among its holdings. This is a return to the name: HRT Financial previously reported a position in CTSO as recently as Q4 2024.

HRT Financial first reported a position in CTSO in Q4 2020 and has held it in 5 quarters since. The position peaked at $121K in Q4 2020. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • HRT Financial held 14,113 shares of Cytosorbents Corp worth $7K as of Q1 2026.
  • Cytosorbents Corp was a new HRT Financial position in Q1 2026.
  • Cytosorbents Corp made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3653 holding.
  • HRT Financial first reported a position in Cytosorbents Corp in Q4 2020 and has held it in 5 quarters since.
  • HRT Financial's Cytosorbents Corp position peaked at $121K in Q4 2020.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.